来那卡帕韦
Lenacapavir (Synonyms: GS-6207)
ChemLeader
产品编号:
CAS No.:
MDLNo:
分子式:
分子量:
选择规格
选择数量
- +
基本信息
中文名称来那卡帕韦
英文名称 Lenacapavir (Synonyms: GS-6207)
CAS号2189684-44-2
分子式C39H32ClF10N7O5S2
分子量968.28
外观White to light yellow powder
储存条件Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
安全信息
产品详情

Lenacapavir (GS-6207) is a novel, first-in-class,long-acting and highly potent HIV-1 capsid inhibitor approved in EU on August 22, 2022 to treat HIV patients infected with multidrug-resistant virus and as a twice-yearly injectable for pre-exposure prophylaxis.

相关文献
相关产品
抱歉,暂时没有相关产品
浏览记录
1-甲基-1-亚硝基-3-((2S,3R,4R,5S,6R)-2,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-3-基)脲; 链脲菌素; 链脲佐菌素
CHIR-99021 盐酸盐 | 拉格鲁西布盐酸盐
Sotuletinib (BLZ945)
重组人白介素 1 α(rHuIL-1 α)
MSG606
来那卡帕韦
(S)-2-(6-(4-氯苯基)-8-甲氧基-1-甲基-4H-苯并[f][1,2,4]三唑[4,3-a][1,4]二氮杂卓-4-基)-N-乙基乙酰胺 |I-BET762 | GSK525762 | GSK525762A
2-脱氧-2-氟-L-岩藻糖
Valemetostat
特戈拉赞